Learn more

INST RECH S CLINIQUES DE MONTR

Overview
  • Total Patents
    41
About

INST RECH S CLINIQUES DE MONTR has a total of 41 patent applications. Its first patent ever was published in 1984. It filed its patents most often in Canada, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are HELMHOLTZ ZENTRUM MUENCHEN, UNIV ERASMUS MED CT ROTTERDAM and HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM GESUNDHEIT & UMWELT GMBH.

Patent filings per year

Chart showing INST RECH S CLINIQUES DE MONTRs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Durand Louis-Gilles 9
#2 Pibarot Philippe 6
#3 Sauvageau Guy 6
#4 Xu Jingping 6
#5 Seidah Nabil G 6
#6 Krosl Jana 5
#7 Humphries Keith 5
#8 Chretien Michel 5
#9 Marcinkiewicz Mieczyslaw 4
#10 Jolicoeur Paul 4

Latest patents

Publication Filing date Title
WO2009143633A1 Pcsk9 inhibitors and methods of use thereof
WO2009115927A2 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use
WO2009036573A1 Apparatus and method for monitoring cell behaviour
CN102099367A Nucleoside and nucleotide analogues with quaternary carbon centers and methods of use
WO2007128121A1 Chimeric pcsk9 proteins, cells comprising same, and assays using same
WO2007030937A2 Screening proteinase modulators using a chimeric protein and ski-i proprotein convertase substrates and inhibitors
US2010015654A1 Negative regulation of NK cell functions by EAT-2, a sap-related adaptor expressed in innate immune cells
CA2469089A1 En-2 gene, disgnostic and therapeutic uses thereof
AU2003273689A8 Stem cell expansion factor blocking a gene limiting hox-induced expansion and method thereof
CA2466100A1 Multimodality imaging phantom and process for manufacturing said phantom
CA2399781A1 Cellular and molecular basis for anti-alzheimer treatment by blocking mrna dendritic transport from cell body to senile plaque and by this the prevention of senile plaque formation
US6368283B1 Method and apparatus for estimating systolic and mean pulmonary artery pressures of a patient
CA2313828A1 Post-translational processing of .beta.-secretase (bace): the pro-and transmembrane/cytosolic domains affect its cellular activity and amyloid a.beta. production
CA2349587A1 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity
CA2277089A1 Method for measuring de novo t-cell production in humans
US6241683B1 Phonospirometry for non-invasive monitoring of respiration
CA2249648A1 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity
CA2289236A1 Transgenic mice expressing hiv-1 in immune cells
CA2274804A1 Nur-re a response element which binds nur nuclear receptors and method of use therefor
US6268211B1 Non-infectious HIV transgene